11885909 HighRisk Newborns and Child During Illness and Hospitalization Pediatric Nursing 2
THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise...
Transcript of THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise...
![Page 1: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/1.jpg)
THE RELENTLESS DRIVE TOLOW RISK: OBSTACLESAND OPPORTUNITIES
Michael J. Reardon, M.D.
Professor of Cardiothoracic Surgery
Allison Family Distinguish Chair of Cardiovascular
Research
Houston Methodist DeBakey Heart & Vascular Center
![Page 2: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/2.jpg)
COI
Steering committeesCoreValveEvolut RSurTAVI
Reprise IIISalus
National Surgical PISurTAVI
Reprise IIIEvolut R low risk trial
![Page 3: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/3.jpg)
EXTREMERISK
DONE
DONE
![Page 4: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/4.jpg)
HIGH RISK
DONE
DONE
![Page 5: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/5.jpg)
HIGH RISK CLINICALOUTCOMES
![Page 6: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/6.jpg)
Events TAVR SAVRP
Value
Life threateningor disablingbleeding
19.1 41.3 <0.001
Acute kidney injury 6.2 15.1 <0.001
Atrial fibrillation 19.8 36.3 <0.001
Reintervention 2.5 0.4 0.020
Major vascular complications 7.1 2.0 0.001
Pacemaker implant 28.0 14.5 <0.001
Aortic valve hospitalization 27.6 21.9 0.087
Endocarditis 0.9 1.7 0.346
6
![Page 7: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/7.jpg)
Subgroup
All-cause Deathat 3 YearsKM
RatesHazard Ratios
(95%CI)
Interaction PValue
TAVR SAVRAge 0.35
>85 38.8 41.9 0.89 (0.63, 1.24)≤85 27.5 36.8 0.70 (0.49, 1.00)
Gender 0.65Male 34.8 40.7 0.84 (0.60, 1.16)Female 30.7 37.1 0.75 (0.52, 1.08)
BMI 0.82≤30 35.4 41.3 0.80 (0.60, 1.06)>30 26.5 34.2 0.75 (0.46, 1.23)
LVEF 0.24≤60 35.7 38.7 0.89 (0.66, 1.21)>60 28.3 38.8 0.65 (0.43, 1.00)
Diabetes 0.70No 34.7 43.0 0.74 (0.55, 1.01)Yes 29.6 34.5 0.82 (0.55, 1.25)
1.00 2.000.500.250 125
ACC2016 7
![Page 8: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/8.jpg)
Subgroup
All-cause Deathat 3 YearsKM
RatesHazard Ratios
(95%CI)
InteractionP
ValueTAVR SAVR
Prior CABG 0.90No 34.8 42.2 0.78 (0.59, 1.04)Yes 28.3 32.5 0.81 (0.50, 1.32)
PVD 0.56No 34.4 38.6 0.84 (0.61, 1.16)Yes 30.0 38.8 0.73 (0.49, 1.07)
Hypertension
0.46
No 50.4 59.8 0.56 (0.21, 1.44)Yes 32.1 38.2 0.80 (0.62, 1.03)
STSScore 0.14≤7% 27.1 38.5 0.66 (0.46, 0.95)>7% 39.3 39.8 0.95 (0.68, 1.32)
1.00 2.000.500.250 125
ACC2016 8
![Page 9: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/9.jpg)
0
0.001
0.002
0.003
0.004
0.005
0.006
0.007
0 30 60 90 120 150 180 210 240 270 300 330 360
Est
imat
ed
Haza
rdR
ate
Days Post Procedure
HRPivotal TAVR
HRPivotal SAVR
Perip ocedural ElevatedHazard
Constant Hazard
Delayed Recovery
![Page 10: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/10.jpg)
TAVR vs. AVR must showequivalent or better
mortalityhemodynamics
morbidityquality of life
durabilitypatient acceptance
PVL/ Pace
maker
?
What do randomized trial tellus?
![Page 11: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/11.jpg)
TAVR is the treatment ofchoice in anatomically TAVR
suitable high-risk patients
![Page 12: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/12.jpg)
How About Lower Risk Data?
![Page 13: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/13.jpg)
Evolution in Patient Selection inU.S. TAVR Clinical Trials
11 2% 11 0%11.8%
0%
2%
4%
6%
8%
10%
12%
14%
PARTNERBTAVR
PARTNERIIB
SAPIEN
PARTNERIIB
SAPIEN XT
CoreValveER
Iliofemoral
CoreValveER
ContinuedAccess
TVTRegistry
SAPIENTF
PARTNERATAVR
PARTNERTF
ContinuedAccess
CoreValveHR
TVTRegistry
SAPIENTF
STS
Score
Inoperable (extreme risk) High-Risk
![Page 14: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/14.jpg)
Partner IIA
SurTAVI
![Page 15: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/15.jpg)
![Page 16: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/16.jpg)
![Page 17: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/17.jpg)
![Page 18: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/18.jpg)
![Page 19: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/19.jpg)
![Page 20: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/20.jpg)
![Page 21: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/21.jpg)
![Page 22: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/22.jpg)
![Page 23: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/23.jpg)
![Page 24: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/24.jpg)
![Page 25: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/25.jpg)
SurTAVI data will bepresented in 2017
![Page 26: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/26.jpg)
![Page 27: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/27.jpg)
![Page 28: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/28.jpg)
![Page 29: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/29.jpg)
![Page 30: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/30.jpg)
![Page 31: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/31.jpg)
![Page 32: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/32.jpg)
![Page 33: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/33.jpg)
![Page 34: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/34.jpg)
![Page 35: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/35.jpg)
![Page 36: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/36.jpg)
![Page 37: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/37.jpg)
TAVR vs. AVR must showequivalent or better
mortalityhemodynamics
morbidityquality of life
durabilitypatient acceptance
PVL/ Pace
maker
?
Intermediate risk
![Page 38: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/38.jpg)
Low Risk Randomized Trials
![Page 39: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/39.jpg)
![Page 40: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/40.jpg)
UK “ALL-COMERS”TRIAL
Severe symptomatic aortic stenosis
Age ≥80 years (ie all comers in this age group)
Or Age ≥70 years + >/= 1 co-morbid state
Both AVR and TAVI deemed to be acceptable
options (Eligibility determined by the MDT)
Randomised to TAVI or surgical AVR (1:1)
– with any CE marked device
N = 808 patients
Primary end point - All-cause mortality at one year
![Page 41: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/41.jpg)
6.2%
13.9%
79.9%
FDAApproved
FDA Approved
Trials
![Page 42: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/42.jpg)
PVL?
![Page 43: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/43.jpg)
CURRENTHMH VALVES
Nitinol wire frame,bovine tissue
valve; outer PUskirt; mechanical
expansion andlocking
Evolut RSelf-expanding,Nitinol frame, 3
sizes, Recapture,Reposition andRedeployment
balloon exp(4 sizes),
cobalt frame;bovine tissuevalve; outerskirt; precisepositioning
![Page 44: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/44.jpg)
CURRENTHMH VALVES
Polyester fabric cuff withtwo inflatable rings;positioning wires for
placement; bovine tissuevalve
Portico:Nitinol frame, Bovine
and Porcinepericardial valve.
Reposition, redeployand recapture
Open cell and intraannular
![Page 45: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/45.jpg)
68.8%79.5%
72.4%
28.6%15.4%
24.1%
2.6% 5.1% 3.4%100%
TF TAA Overall
None/Trace Mild Moderate Severe
SAPIEN 3 TAVR (CE Study)
Femoral TA All
0.1%
S3PVL at 30
days (n
=1500)
![Page 46: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/46.jpg)
Moderate/severe PVL at 30days is 3.4%
![Page 47: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/47.jpg)
Evolut 2.0
![Page 48: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/48.jpg)
REPRISEII TRIAL
![Page 49: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/49.jpg)
Direct Flow TAVR (DISCOVERY)
![Page 50: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/50.jpg)
24.2
16.9
14.2
11.49.0
4.0 3.41.4 0.6
0
5
10
15
20
25
30
%Pat
ients
wit
hM
od/S
eve
rePV
L
SAPIENXT
PARTNER
II, Inop1
SAPIENPARTNERII Inop1
CoreValveADVANCE2
CoreValveExtreme
Risk3
CoreValve HighRisk4
Portico
CEStudy5
SAPIEN36
DirectFlow
DISCOVER7
LOTUSREPRISE
II &EXT8
N=236 N=225 N=639 N=412 N=356 N=75 N=116 N=74 N=1771Leon M, ACC2013, 2LinkeA, PCR2014. 3PopmaJ, JACC2014; 63(19): 1972-81, 4AdamsD, N Engl JMed 2014; 370: 1790-98. 5Manoharan, et al. TCT2014. 6Webb J, EuroPCR2014. 7Schofer, JACC2013. 8Ian Meredith, London Valves2014. Resultsfrom different studiesnot directlycomparable. Informationprovided for educational purposeonly
1 Month Moderate & Severe PVLTAVI Clinical Trials
![Page 51: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/51.jpg)
29.2
20.9
119.4
6.8 6.14.3
00
5
10
15
20
25
30
3512-mo Mod/ Severe PVLrate
Adverse Clinical OutcomesTAVI Clinical Trials
PARTNERII SAPIEN
XT5
PARTNERII SAPIEN5
PARTNERB
SAPIEN6
CoreValve
ADVANCE1
PARTNERA SAPIEN7
CoreValveHigh Risk3
CoreValveExt Risk4
LOTUSREPRISE
II2
N: 284 276 179 996 348 390 489 120
%o
fPat
ients
1LinkeA, PCR2014., 2Ian Meredith, TCT2014 3AdamsD, N En179gl JMed 2014, 4PopmaJ, JACC2014, 5Leon M, ACC2013., 6Leon, NEJM 2010., 7Smith, NEJM2011.Resultsfrom different studiesnot directly comparable. Information provided for educational purpose only
![Page 52: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/52.jpg)
PREDICTIONS FOR2020
PVL will be largely solvedand similar to SAVR with
engineering designimprovements
![Page 53: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/53.jpg)
78.176.06
78.71 80.07 80.53
77.4
63.89
68.44
74.4976.32
40
50
60
70
80
90
Baseline Discharge 30 days 6 months 12 mo
TAVR
SAVR P=0.023
P=0.19
Volu
me
(mL)
![Page 54: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/54.jpg)
0
20
40
60
80
100
P=0.1288
Seve
rePPM
(%)
TAVR SAVR TAVR SAVR TAVR SAVR
baseline Discharge 12 mo
None Mild Moderate Severe
![Page 55: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/55.jpg)
Prosthesis-Patient Mismatch
• Severe PPM occurssignificantly more afterSAVR than TAVR
Zorn AATS2015
![Page 56: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/56.jpg)
PREDICTIONS FOR2020
SAVR hurts the heart for atleast 6 months and this isunlikely to change by 2020
![Page 57: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/57.jpg)
Durability
![Page 58: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/58.jpg)
![Page 59: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/59.jpg)
![Page 60: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/60.jpg)
![Page 61: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/61.jpg)
![Page 62: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/62.jpg)
![Page 63: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/63.jpg)
DVIR DATA
![Page 64: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/64.jpg)
PREDICTIONS FOR2020
We will not get an answer ondurability until intermediate andlow risk trials reach 10 years
![Page 65: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/65.jpg)
PREDICTIONS FOR2020
SAVR is a mature techniquewhile
TAVR is young and likely tounder go substantial
improvements
Technical disasters have alreadydecreased and will decrease
![Page 66: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/66.jpg)
0
0.001
0.002
0.003
0.004
0.005
0.006
0.007
0 30 60 90 120 150 180 210 240 270 300 330 360
Est
imat
ed
Haza
rdR
ate
Days Post Procedure
HRPivotal TAVR
HRPivotal SAVR
Pe procedural ElevatedHazard
Constant Hazard
DelayedRecovery
![Page 67: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/67.jpg)
PREDICTIONS FOR2020
SAVR is technique drivenTAVR is technology driven
TAVR will enjoy a wideradoption than SAVR
![Page 68: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/68.jpg)
PREDICTIONS FOR2020
We used to ask “Which casesare bad for SAVR” and do
TAVR
We will ask “Which cases arebad for TAVR” and consider
SAVR
![Page 69: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/69.jpg)
PREDICTIONS FOR2020
Surg
icalR
isk
Low Risk Intermediate Risk High Risk Extreme Risk
Both dividing linesmoving to the leftbut how far?Durablity
![Page 70: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/70.jpg)
PREDICTIONS FOR2020
Surg
icalR
isk
Low Risk Intermediate Risk High Risk Extreme Risk
Both dividing linesmoving to the leftbut how far?
If proven durablity found
All risk categories will be TAVR candidates
![Page 71: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/71.jpg)
Thank You
![Page 72: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/72.jpg)
0.0
10.0
20.0
30.0
40.0
50.0
60.0
Baseline Discharge 1 Month 1 Year 2 Years 3 Years
TAVR SAVR
AV
Mean
Gra
die
nt,
mm
Hg
In 18 TAVR(9.5%) and 17 SAVR(12.6%) with a >50%increase in AV mean gradient:
72*Site-reported
Structural Hemodynamic Deterioration*ACC2016
![Page 73: THERELENTLESSDRIVETOLOWRISK: OBSTACLES AND …€¦ · Salus National Surgical PI SurTAVI Reprise III Evolut R low risk trial. EXTREMERISK DONE DONE. HIGHRISK ... valve; outer PU](https://reader034.fdocuments.net/reader034/viewer/2022042412/5f2c0f82fde2a576df72e05c/html5/thumbnails/73.jpg)
6.2%
13.9%
79.9%
FDAApproved
FDA Approved
Trials